Sanofi (SNY) Total Non-Current Liabilities (2009 - 2025)

Sanofi has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $31.1 billion for Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $31.1 billion, up 13.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $31.1 billion (up 13.04% YoY), and the FY2025 annual result was $31.1 billion, up 13.04% from the prior year.
• Total Non-Current Liabilities came in at $31.1 billion for Q4 2025 at Sanofi, up from $29.0 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $35.9 billion in Q2 2021 to a low of $27.5 billion in Q4 2024.
• The 5-year median for Total Non-Current Liabilities is $30.0 billion (2023), against an average of $30.5 billion.
• Across the five-year window, Total Non-Current Liabilities dropped 17.73% in 2022 and grew 13.04% in 2025, its largest moves.
• Sanofi's Total Non-Current Liabilities stood at $34.2 billion in 2021, then decreased by 17.73% to $28.2 billion in 2022, then climbed by 6.64% to $30.0 billion in 2023, then fell by 8.25% to $27.5 billion in 2024, then increased by 13.04% to $31.1 billion in 2025.
• The last three Total Non-Current Liabilities figures came in at $31.1 billion (Q4 2025), $29.0 billion (Q2 2025), and $27.5 billion (Q4 2024), per Business Quant data.